mirtazapine has been researched along with Dyskinesia, Medication-Induced in 7 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aripiprazole is a novel antipsychotic medication characterized by partial agonism at the D2 and 5-HT1A receptors and by antagonism at the 5-HT2A receptor." | 2.74 | Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study. ( Bernardi, S; Edito, F; Meco, G; Purcaro, C; Stirpe, P; Valente, M; Vanacore, N, 2009) |
| " Adding risperidone to mirtazapine probably does not necessitate a change of the dosage of either drug, but more extensive investigations are needed." | 2.69 | Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study. ( Doorschot, CH; Loonen, AJ; Oostelbos, MC; Sitsen, JM, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hutchins, D | 1 |
| Hall, J | 1 |
| Sharma, A | 1 |
| Hamadjida, A | 1 |
| Nuara, SG | 1 |
| Veyres, N | 1 |
| Frouni, I | 1 |
| Kwan, C | 1 |
| Sid-Otmane, L | 1 |
| Harraka, MJ | 1 |
| Gourdon, JC | 1 |
| Huot, P | 1 |
| Meco, G | 1 |
| Stirpe, P | 1 |
| Edito, F | 1 |
| Purcaro, C | 1 |
| Valente, M | 1 |
| Bernardi, S | 1 |
| Vanacore, N | 1 |
| Konitsiotis, S | 1 |
| Pappa, S | 1 |
| Mantas, C | 1 |
| Mavreas, V | 1 |
| Kohen, I | 1 |
| Sarcevic, A | 1 |
| Pact, V | 1 |
| Giduz, T | 1 |
| Loonen, AJ | 1 |
| Doorschot, CH | 1 |
| Oostelbos, MC | 1 |
| Sitsen, JM | 1 |
2 trials available for mirtazapine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Antipsychot | 2009 |
Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depression; Depressive Disorder | 1999 |
5 other studies available for mirtazapine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Mirtazapine-Induced Transient Dyskinesia.
Topics: Antidepressive Agents; Dyskinesia, Drug-Induced; Female; Humans; Mental Disorders; Middle Aged; Mirt | 2019 |
The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset.
Topics: Animals; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Behavior, Animal; Callithrix; Dyski | 2017 |
Acute reversible dyskinesia induced by mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Humans; Male | 2005 |
Mirtazapine in bupropion-induced dyskinesias: a case report.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Dyskinesia, D | 2006 |
Mirtazapine treats resting tremor, essential tremor, and levodopa-induced dyskinesias.
Topics: Adrenergic alpha-Antagonists; Aged; Dyskinesia, Drug-Induced; Dyskinesias; Female; Humans; Levodopa; | 1999 |